Clinical trial Recruiting at 1 site Interventional Ages 18 and up

SHAPE vs. Milligan-Mordon hemorrhoidectomy for advanced hemorrhoids

Official title: Early Outcomes of Skin-Sparing Hemorrhoidectomy and PExy (SHAPE) Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease: A Randomized Controlled Trial

Run by Cairo University · NCT07598630 · Data updated 2026-11-12

This trial tests whether Skin-Sparing Hemorrhoidectomy and PExy (SHAPE) works as well as the conventional Milligan-Morgan procedure for adults with severe hemorrhoids.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment68 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Al-Manial, Cairo, Egypt)
StatusRecruiting
StartedMay 24, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedMay 20, 2026
Trial IDNCT07598630 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with third- or fourth-degree hemorrhoids who consent and do not have inflammatory bowel disease, anal stenosis, colorectal cancer, or fecal incontinence.

Probably not a fit

Patients with the specified exclusion criteria or conditions not responsive to the surgical approaches may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two surgical approaches for third- and fourth-degree hemorrhoids at Kasr Al-Ainy Teaching Hospital, Cairo University. Adults over 18 who meet criteria will be assigned to SHAPE or Milligan-Morgan hemorrhoidectomy after preoperative evaluation. Postoperative care includes early fluids, with discharge typically on day one if recovery is uneventful. Exclusion criteria include inflammatory bowel disease, anal stenosis, colorectal malignancy, or fecal incontinence. The study aims to determine differences in outcomes such as symptom relief and recovery between the two techniques.

Why it matters

Potential benefit: If SHAPE proves at least as effective and safe as Milligan-Morgan, patients could benefit from comparable disease control with potential improvements in recovery or pain.

How similar studies have gone: Little evidence is available in this setting; the trial explores a direct comparison to establish applicability and efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients with third- and fourth-degree piles, and their age greater than 18 years old

Exclusion Criteria:

* Patients with inflammatory bowel disease.
* Patients with anal stenosis
* Patients with colorectal malignancy
* Patient with fecal incontinence

Where it's running

  • Faculty of medicine, Cairo University
    Cairo, Al-Manial, Cairo, Egypt, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.